Introduction
Multiple myeloma (MM), the second most common devastating clonal plasma cell malignancy, occurs in bone marrow with a 45% 5-year survival rate; its characteristics include uncontrolled proliferation, complex chromosomal instability and accumulation of plasma cells.
1,2 MM accounts for 1% of all cancers and 1%-10% of all clonal plasma cell malignancies. 3 In addition, more than 40,000 cases are being diagnosed in Europe, and the annual incidence of MM is increasing progressively with age. 4 Though a number of novel pharmacological strategies have been developed in the past 30 years, including the introduction of new immunomodulatory drugs and proteasome inhibitors, MM still remains an incurable disease. 5 Thus, new drugs with increased therapeutic efficacy to treat MM are of greater demand.
3,4,5′-trihydroxystibene-3-monoglucoside (polydatin, PD), a monocrystalline drug and a glycoside form of resveratrol used in traditional Chinese therapy, is one of the key effective components found in the root and rhizome of herb Polygonum cuspidatum. 6 Previous pharmacological research and clinical application manifested that PD was mainly used in suppressing platelet aggregation, reducing blood lipid, restoring microcirculation and protecting from myocardial ischemia/reperfusion injury and shock. [6] [7] [8] [9] PD also possesses anticancer activity. For instance, Wang et al showed that PD effectively suppressed cell proliferation and induced cell cycle arrest in S phase and apoptosis of acute monocytic leukemia. 10 Xu et al reported that PD inhibited cell growth by suppressing β-catenin signaling pathway and promoted apoptosis by raising the ratio of Bax/Bcl-2 in human osteosarcoma cells. 11 Zhang et al found that PD showed a significant proliferation inhibition, dose-dependent apoptosis induction and cell cycle arrest in lung cancer. 12 However, the effect of PD on MM has not been elucidated.
Mammalian target of rapamycin (mTOR) is located at the intersection of different signal pathways, including Ras, phosphoinositide-3 kinase (PI3K)/protein kinase B (AKT) and nuclear factor-kappa B, toward mRNA, ribosome and protein synthesis. 13 It was reported that mTOR gets activated and plays an important role in the cell proliferation and growth of tumor cells when its downstream target ribosomal p70S6 kinase (p70s6k) is phosphorylated. 14, 15 In mammalian cells, mTOR/p70s6k signaling pathway is also associated with autophagy when cells encounter conditions such as tumor suppression, oxidative stress and infection. 16 Besides, activation of the mTOR/p70s6k signaling pathway plays a crucial role in tumorigenesis, angiogenesis and tumor proliferation. [17] [18] [19] Pang et al revealed that celastrol inhibited cell growth and angiogenesis in prostate cancer by targeting the AKT/mTOR/p70s6k signaling pathway induced by vascular endothelial growth factor. 20 However, the interrelation between PD and mTOR/p70s6k signaling pathway remains unclear. The aim of this study was to investigate the effect of PD on MM cells and its underlying molecular mechanism. 
Materials and methods

Western blot analysis
After the RPMI 8226 cells were collected and lysed, the concentration of proteins was determined by bicinchoninic acid Protein Assay Kit (CoWin Biotechnology, Beijing, People's Republic of China). Equal amount of proteins were loaded on a 10% sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) and then blotted to polyvinylidene fluoride membranes. The membranes were blocked with 1× PBS containing 5% skimmed milk 
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effect of polydatin on multiple myeloma cells and 0.1% Tween-20 and then incubated with desired primary antibodies (anti-Bcl-2, anti-Bax, anti-caspase-3, anti-cleaved caspase-3, anti-caspase-9, anti-cleaved caspase-9, anti-Beclin 1, anti-Atg5, anti-LC3I, anti-LC3II, anti-heat shock protein (HSP)70, anti-HSP27, anti-t-mTOR, anti-t-p70s6k, anti-p-mTOR, anti-p-p70s6k and anti-β-Actin) (Santa Cruz Biotechnology, Santa Cruz, CA, USA) overnight at 4°C. After washing three times with PBS, the membranes were immunoblotted with appropriate secondary antibodies and incubated for 1 h at room temperature. The immunoreactive bands of specific proteins were visualized by enhanced chemiluminescence (Santa Cruz Biotechnology) and analyzed using an Image Scanner (Amersham Biosciences, Uppsala, Sweden). β-actin was used as an internal control.
statistical analysis
Data from each group were expressed as mean ± standard deviation (SD) or mean ± standard error. SPSS19.0 software package (SPSS Inc., Chicago, IL, USA) was used to analyze all statistics. Differences between two groups were performed using the Student's t-test and differences among multiple groups were analyzed by using one-way analysis of variance. P,0.05 was considered to indicate a statistically significant difference. 
Results
PD
PD induced apoptosis of rPMi 8226 cells
To further assess the cytotoxicity of PD on RPMI 8226 cells, the cells were treated with various concentrations (0, 50, 100 and 200 μmol/L) of PD for 24 h. Subsequently, the cells were double stained by Annexin V-FITC/PI and apoptosis was assessed by flow cytometry. The results obtained demonstrated that the apoptosis rates dramatically increased in a concentration-dependent manner (Figure 2A ). Besides, apoptosis indicator, such as cleaved caspase-3, cleaved caspase-9 and proapoptotic protein Bax, were upregulated in a concentration-dependent manner, while antiapoptotic protein Bcl-2 was downregulated with increased concentrations of PD treatment ( Figure 2B ).These results suggest that PD contributed to the induction of apoptosis.
PD induced autophagy in rPMi 8226 cells
To further study the effect of PD on autophagy, the levels of autophagy markers LC3I and LC3II and autophagy-related proteins Atg5 and Beclin 1 were detected by Western blot. As shown in Figure 3A and B, PD significantly increased the expression of Beclin 1, Atg5 and LC3II. Moreover, an augmentation in the conversion of cytosolic form of LC3 (LC3I) into active membrane-bound form of LC3 (LC3II) Figure 1 effect of PD on proliferation in rPMi 8226 cells. ccK-8 assay was used to examine the cell viability after rPMi 8226 cells were treated with PD at different concentrations for 24 h and 48 h. each group was analyzed by three independent experiments. Data are presented as mean ± seM. *P,0.05, **P,0.01, ***P,0.001, compared to 0 μmol/l. Abbreviations: seM, standard error of the mean; PD, polydatin; ccK-8, cell counting kit8. 
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Yang and Zhao (ie, the ratio of LC3II/I) was detected in a concentrationdependent manner ( Figure 3C ). In addition, the relationship between the level of HSP and autophagy was assessed by Western blot and the results revealed that the expressions of HSP27 and HSP70 were significantly decreased when the cells were treated with PD ( Figure 3D and E).
3-Ma overturned the inhibitory effect of PD on proliferation and attenuated the induced effect of PD on apoptosis and autophagy in rPMi 8226 cells PD suppressed the activation of mTOr/ p70s6k signaling pathway in rPMi 8226 cells
Since mTOR/p70s6k signaling pathway played a crucial role in regulating apoptosis and autophagy, the effect of PD on mTOR/p70s6k signaling pathway was investigated. The expression levels of key components in this pathway were examined by Western blot. As shown in Figure 5A and B, PD effectively decreased the phosphorylation of mTOR and p70s6k compared with the control, indicating that PD could effectively suppress mTOR/p70s6k signaling pathway.
rapamycin inhibited viability and induced apoptosis and autophagy in a concentration-dependent manner in rPMi 8226 cells
Rapamycin, a specific inhibitor of mTOR/p70s6k signaling pathway, was used to further determine the role of mTOR/p70s6k signaling pathway in MM cells. The results showed that compared with control group, an increased expression of Beclin 1 and Atg5 and conversion of endogenous LC3I into LC3II were observed in rapamycin-treated cells ( Figure 6A-C) . Meanwhile, rapamycin treatment led to an evident decrease in cell viability ( Figure 6D ) and an obvious increase in apoptosis rates compared with control group (Figure 6E) . Moreover, Bax, caspase-3 and caspase-9 expressions were strikingly elevated and Bal-2 was drastically reduced in cells treated with rapamycin ( Figure 6F and G). In summary, pretreatment of rapamycin significantly inhibited viability, promoted apoptosis and induced autophagy in RPMI 8226 cells.
MhY1485 relieved the inhibitory effect of PD on proliferation and attenuated the induced effect of PD on apoptosis and autophagy in rPMi 8226 cells mTOR activator MHY1485 was used to further verify the effect of activation of the mTOR/p70s6k signaling pathway on cytotoxicity of PD in RPMI 8226 cells. CCK-8 assay showed that cell viability of RPMI 8226 was significantly higher in PD + MHY1485 group than that in PD group ( Figure 7A ). Flow cytometry results indicated that PD markedly promoted apoptosis of RPMI 8226 cells, whereas MHY1485 strikingly attenuated this effect ( Figure 7B ). Furthermore, Western blot analysis exhibited that PD treatment remarkably improved the levels of Beclin 1, Atg5 and LC3II and the ratio of LC3II/LC3I, which was obviously abated by MHY1485 ( Figure 7C ). Taken together, these findings revealed that activation of the mTOR/p70s6k signaling pathway conspicuously attenuated the inhibitory effect of PD on proliferation and abrogated the induced effect of PD on apoptosis and autophagy in RPMI 8226 cells. 
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Discussion
MM treatment has achieved greater development in recent years due to the application of novel efficient agents such as immunomodulatory drugs and proteasome inhibitors.
However, although response rate and overall survival of MM patients have increased, most of the patients appear to relapse or remain refractory to therapy. Thus, it is of high significance to find new therapeutic strategies for MM treatment. Previous studies have found that PD played a potential role in inhibiting the proliferation of various tumors, such as in leukemia, breast cancer, lung cancer, cervical cancer and liver cancer 12 and showed less toxicity to normal cells. However, little is known about the effect of PD on MM cells. Our results showed that PD functioned as a tumor suppressor in MM cells. The proliferation of MM cells decreased and apoptosis increased progressively along with the increasing concentrations of PD. In addition, it is indicated that cleaved caspase-3 and cleaved caspase-9 levels gradually increased along with the increasing concentrations of PD. Meanwhile, induction of apoptosis was accompanied by the downregulation of Bcl-2 and upregulation of Bax. That is, PD suppressed proliferation and promoted apoptosis of MM cells in timeand concentration-dependent manners. PD was previously regarded as a good therapeutic agent that induces apoptosis in cancer cells. 21, 22 Thus, PD may be used as a potent anticancer drug in MM therapy. A great many anticancer drugs inhibit tumor progression by inducing apoptosis. For example, in head and neck squamous carcinoma, dihydromyricetin increased the rate of apoptosis via the reactive oxygen species (ROS)-signal transducer and activator of transcription-3 (STAT-3) signaling pathways. 23 Cryptotanshinone induced apoptosis and prevented cell migration and invasion of melanoma cancer by ROS-mitochondrial apoptotic pathway and thus might be a potential anticancer drug for human melanoma treatment. 24 Autophagy is a process by which cells degrade the damaged organelles and waste proteins. 25, 26 Under stress situations, autophagy provides required nutrients to meet the needs of cellular metabolism and maintain a healthy cellular homeostasis and plays a crucial pro-survival role. 27 Few agents have been reported to induce apoptosis and activate autophagy. 
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effect of polydatin on multiple myeloma cells pathway in head and neck squamous carcinoma. 23 Luo et al reported that quercetin nanoparticle promoted apoptosis and autophagy and suppressed cell growth by inhibiting JAK2 expression in cervical cancer. 28 In this study, expression of autophagy-associated proteins was detected, such as Beclin 1, Atg5 (related to autophagosomes formation), LC3I (cytosolic form of key protein LC3 in autophagosome formation), LC3II (active membrane-bound form of LC3), HSP27 and HSP70. Western blot analysis showed that PD significantly augmented the levels of Beclin 1 and Atg5 in a concentration-dependent manner. PD treatment resulted in an increase in the ratio of LC3II/LC3I, generally accepted markers of autophagy, and a decrease in autophagy-associated proteins HSP27 and HSP70. Besides, this study has been found that the cell viability of RPMI 8226 cells, when treated with autophagy inhibitor 3-MA and PD, significantly increased compared with PD-treated group, whereas both apoptosis and autophagy induced by PD treatment obviously diminished when RPMI 8226 cells were incubated with 3-MA, which indicates that PD can also induce autophagy in addition to inhibiting apoptosis and proliferation in RPMI 8226 cells.
Therefore, this study has found that PD treatment significantly inhibited the phosphorylation of mTOR and p70s6k, which indicates that the mTOR/p70s6k signaling pathway might be a potential target pathway of PD. Previously, the PI3K/AKT/mTOR/p70s6k signaling pathway has been found to be the target pathway of mollugin, gefitinib and pogostone inducing autopathy and apoptosis in glioblastoma cells, lung cancer and colorectal carcinoma. 27, 29, 30 The mTOR/p70s6k signaling pathway plays an important role in the regulation of autophagy, cell proliferation and cell survival in eukaryotic cells. 31, 32 In our study, the levels of autophagy-associated proteins, such as Beclin 1, Atg5, LC3I and LC3II, pro-apoptotic protein Bax, cleaved caspase-3, cleaved caspase-9 and the ratio of LC3II/LC3I, markedly increased after RPMI 8226 cells were treated with mTOR/p70s6k signaling pathway-specific inhibitor (rapamycin). Meanwhile, the anti-apoptotic protein Bcl-2 level was suppressed and cell viability dramatically decreased with rapamycin treatment. In addition, our results further implicated that activation of mTOR/p70s6k signaling pathway significantly eliminated the inhibitory effect of PD on proliferation and overturned PD-induced apoptosis and autophagy in RPMI 8226 cells. All these results demonstrated that inhibition of mTOR/p70s6k signaling pathway resulted in the inhibition of cell growth and induction of apoptosis and autophagy, while activation of this pathway showed the opposite effects, which is in agreement with the previous studies.
Conclusion
PD effectively suppressed cell growth and induced apoptosis and autophagy in MM cells through mTOR/p70s6k signaling pathway in vitro, which indicates that PD could be used as a potential anticancer drug for MM treatment. However, further research is needed to explore the anticancer effect of PD in vivo.
